{
  "id": 16626320,
  "title": "Roche’s changing plans show how MFN is complicating European drug launches",
  "url": "https://urgent.news/2026/10/26/roches-changing-plans-show-how-mfn-is-complicating-european-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-26T16:06:38.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/roches-changing-plans-show-how-mfn-is-complicating-european-drug-launches/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Roche will seek European approval for its promising new breast cancer pill giredestrant later than it once expected, highlighting how US drug pricing pressure may be affecting pharmaceutical companies’ launch strategies elsewhere. As recently as ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}